FDA recall D-0622-2018
Elroselabs Inc. · Class II · drug
Product
Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.
Reason for recall
cGMP Deviations
Distribution
Nationwide.
Key facts
- Status
- Terminated
- Initiation date
- 2018-03-28
- Report date
- 2018-04-18
- Termination date
- 2020-12-15
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Sanford, FL, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0622-2018